NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Voltar para busca
Dado oficial do USPTO
T-THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
T-THERAPEUTICS
ST13
US500000098081081Classe
5, 9, 42, 44
Pedido
98081081
Registro
8330457
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
07/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 42, 44
Data de depósito
12/07/2023
Data de registro
07/07/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/07/2026
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Cambridge, GB
Examinador
ANDERSON, DANIELLE LYNN
Unidade examinadora
M40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
T-Therapeutics Limited
Representantes
Stacy J. Grossman Law Office of Stacy J. Grossman PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; pharmaceutical preparationsin particularchemical and biological preparations for medical purposesfor the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; chemical preparations for use in DNA analysis for medical purposes; DNA synthesis inhibitors for medical purposespharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral and bacterial infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; immunotherapeutic drugs namelypharmaceutical preparations for the protection from and prevention of viral and bacterial infectionscancerinflammationautoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; excluding preparations for RNA-based gene silencing
Classe 9
Downloadable computer software for use in collectinganalyzing and organizing data in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; downloadable computer software for use in collectinganalyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling; downloadable software for research and development in the nature of collectinganalyzing and organizing data in the field of antibodies; devices for analyzing genome informationlaboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualizationscientific analysis of genetic sequences; downloadable software for the managinganalysisvisualization of biological data; excluding software and devices for RNA-based gene silencing and hepatocyte-specific computational biology
Classe 42
Scientific and technological servicesscientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for protection from infectionscancerdisease or inflammation; technical research in the field of pharmaceutical studies; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; platform as a service (PAAS) featuring DNA analysis software platforms; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticalsbiopharmaceutical drug development and genome engineering; software as a service (SAAS) services featuring DNA analysis software; provision of online non-downloadable software for the managementvisualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; excluding services related to RNA-based gene silencing and hepatocyte-specific computational biology
Classe 44
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNAgeneticsgenetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes provided by medical laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/05/2026
PUBO
PUBLISHED FOR OPPOSITION
19/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/04/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
21/04/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/04/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
21/04/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/04/2026
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/01/2026
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
30/06/2025
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
20/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/04/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/12/2024
GNSL
LETTER OF SUSPENSION E-MAILED
16/12/2024
CNSL
SUSPENSION LETTER WRITTEN
16/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/10/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2024
GNRT
NON-FINAL ACTION E-MAILED
10/07/2024
CNRT
NON-FINAL ACTION WRITTEN
10/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
31/05/2024
GRML
CORRESPONDENCE E-MAILED
27/03/2024
CNRT
NON-FINAL ACTION WRITTEN
27/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/03/2024
DOCK
ASSIGNED TO EXAMINER
20/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2023
NWAP
NEW APPLICATION ENTERED
15/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace T-THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.